FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2096984838> ?p ?o ?g. }

• W2096984838 endingPage "4594" @default.
• W2096984838 startingPage "4587" @default.
• W2096984838 abstract "Purpose Diffuse large B-cell lymphoma (DLBCL) includes at least two prognostically important subtypes (ie, germinal center B-cell–like [GCB] and activated B-cell–like [ABC] DLBCL), which initially were characterized by gene expression profiling and subsequently were confirmed by immunostaining. However, with the addition of rituximab to standard chemotherapy, the prognostic significance of this subclassification of DLBCL is unclear. Patients and Methods We studied 243 patient cases of de novo DLBCL, which included 131 patient cases treated with rituximab plus standard chemotherapy (rituximab group) and 112 patient cases treated with only standard chemotherapy (control group). The cases were assigned to GCB or non-GCB subgroups (the latter of which included both ABC DLBCL and unclassifiable DLBCL) on the basis of immunophenotype by using the Hans method. Clinical characteristics and survival outcomes of the two patient groups were compared. Results The clinical characteristics of the patients in the rituximab and the control groups were similar. Compared with the control group, addition of rituximab improved the 3-year overall survival (OS; 42% v 77%; P < .001) of patients with DLBCL. Rituximab-treated patients in either the GCB or the non-GCB subgroups also had a significantly improved 3-year OS compared with their respective subgroups in the control group (P < .001). In the rituximab group, the GCB subgroup had a significantly better 3-year OS than the non-GCB subgroup (85% v 69%; P = .032). Multivariate analyses confirmed that rituximab treatment was predictive for survival in both the GCB and the non-GCB subgroups. Conclusion In this retrospective study, we have shown that the subclassification of DLBCL on the basis of the cell of origin continues to have prognostic importance in the rituximab era." @default.
• W2096984838 created "2016-06-24" @default.
• W2096984838 creator A5001659843 @default.
• W2096984838 creator A5006953004 @default.
• W2096984838 creator A5007853425 @default.
• W2096984838 creator A5015247283 @default.
• W2096984838 creator A5015628512 @default.
• W2096984838 creator A5022164102 @default.
• W2096984838 creator A5041701143 @default.
• W2096984838 creator A5046438171 @default.
• W2096984838 creator A5049160636 @default.
• W2096984838 creator A5058851884 @default.
• W2096984838 creator A5061471602 @default.
• W2096984838 creator A5064436224 @default.
• W2096984838 creator A5080373697 @default.
• W2096984838 date "2008-10-01" @default.
• W2096984838 modified "2023-10-03" @default.
• W2096984838 title "Addition of Rituximab to Standard Chemotherapy Improves the Survival of Both the Germinal Center B-Cell–Like and Non–Germinal Center B-Cell–Like Subtypes of Diffuse Large B-Cell Lymphoma" @default.
• W2096984838 cites W1512720088 @default.
• W2096984838 cites W1853245606 @default.
• W2096984838 cites W1965985271 @default.
• W2096984838 cites W1976564639 @default.
• W2096984838 cites W1976835009 @default.
• W2096984838 cites W1979419663 @default.
• W2096984838 cites W1986602474 @default.
• W2096984838 cites W1992076386 @default.
• W2096984838 cites W1997236192 @default.
• W2096984838 cites W2002161324 @default.
• W2096984838 cites W2006342636 @default.
• W2096984838 cites W2014651001 @default.
• W2096984838 cites W2017009058 @default.
• W2096984838 cites W2017978260 @default.
• W2096984838 cites W2028096444 @default.
• W2096984838 cites W2032423298 @default.
• W2096984838 cites W2035277855 @default.
• W2096984838 cites W2040426470 @default.
• W2096984838 cites W205637700 @default.
• W2096984838 cites W2058015212 @default.
• W2096984838 cites W2059949924 @default.
• W2096984838 cites W2064208261 @default.
• W2096984838 cites W2065316818 @default.
• W2096984838 cites W2066485964 @default.
• W2096984838 cites W2069524809 @default.
• W2096984838 cites W2075696892 @default.
• W2096984838 cites W2078147862 @default.
• W2096984838 cites W2080501134 @default.
• W2096984838 cites W2090197144 @default.
• W2096984838 cites W2091188527 @default.
• W2096984838 cites W2111163870 @default.
• W2096984838 cites W2111500154 @default.
• W2096984838 cites W2125378800 @default.
• W2096984838 cites W2128402413 @default.
• W2096984838 cites W2136426653 @default.
• W2096984838 cites W2136627244 @default.
• W2096984838 cites W2138498369 @default.
• W2096984838 cites W2139204503 @default.
• W2096984838 cites W2139954541 @default.
• W2096984838 cites W2142242441 @default.
• W2096984838 cites W2142444726 @default.
• W2096984838 cites W2142766411 @default.
• W2096984838 cites W2144881954 @default.
• W2096984838 cites W2145304413 @default.
• W2096984838 cites W2147246240 @default.
• W2096984838 cites W2151532776 @default.
• W2096984838 cites W2151638388 @default.
• W2096984838 cites W2152006714 @default.
• W2096984838 cites W2153230421 @default.
• W2096984838 cites W2153665789 @default.
• W2096984838 cites W2158267770 @default.
• W2096984838 cites W2160305510 @default.
• W2096984838 cites W2164363164 @default.
• W2096984838 cites W2167571754 @default.
• W2096984838 cites W2168438686 @default.
• W2096984838 cites W2276408020 @default.
• W2096984838 cites W2551422852 @default.
• W2096984838 cites W2554524314 @default.
• W2096984838 cites W2564657504 @default.
• W2096984838 cites W3112177578 @default.
• W2096984838 cites W60759546 @default.
• W2096984838 doi "https://doi.org/10.1200/jco.2007.15.9277" @default.
• W2096984838 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18662967" @default.
• W2096984838 hasPublicationYear "2008" @default.
• W2096984838 type Work @default.
• W2096984838 sameAs 2096984838 @default.
• W2096984838 citedByCount "289" @default.
• W2096984838 countsByYear W20969848382012 @default.
• W2096984838 countsByYear W20969848382013 @default.
• W2096984838 countsByYear W20969848382014 @default.
• W2096984838 countsByYear W20969848382015 @default.
• W2096984838 countsByYear W20969848382016 @default.
• W2096984838 countsByYear W20969848382017 @default.
• W2096984838 countsByYear W20969848382018 @default.
• W2096984838 countsByYear W20969848382019 @default.
• W2096984838 countsByYear W20969848382020 @default.
• W2096984838 countsByYear W20969848382021 @default.
• W2096984838 countsByYear W20969848382022 @default.
• W2096984838 countsByYear W20969848382023 @default.
• W2096984838 crossrefType "journal-article" @default.

• next